The State AG Report Weekly Update November 29, 2018


Pharmaceuticals

Florida Attorney General Files Amended Complaint in Opioid Lawsuit (Read More)



The State AG Report Weekly Update November 15, 2018


Pharmaceuticals

New Jersey Attorney General Files Lawsuit Against Opioid Manufacturer for Allegedly Deceptive Marketing and Misrepresenting Risks of Prescription Opioids (Read More)



The State AG Report Weekly Update November 1, 2018


Pharmaceuticals

Kentucky Attorney General Files Lawsuit Against Opioid Manufacturer for Allegedly Off-Label Marketing and Misrepresenting Risks of Prescription Opioids (Read More)



The State AG Report Weekly Update October 25, 2018


Pharmaceuticals

Wyoming Attorney General Files Lawsuit Against Opioid Manufacturers for Allegedly Misrepresenting Risks of Prescription Opioids (Read More)



The State AG Report Weekly Update October 18, 2018


Pharmaceuticals

Minnesota Attorney General Files Lawsuit Against Insulin Manufacturers Over Allegedly Artificially-Inflated Prices (Read More)



The State AG Report Weekly Update September 20, 2018


Pharmaceuticals

Oregon Attorney General Sues Opioid Manufacturer for Allegedly Violating a Prior Settlement and State Law Over Opioid Marketing (Read More)



The State AG Report Weekly Update September 13, 2018


Pharmaceuticals

Arizona Attorney General Sues Opioid Manufacturer for Allegedly Violating Consent Judgment Regarding Allegedly Deceptive Marketing of Prescription Opioids (Read More)



The State AG Report Weekly Update September 6, 2018


Pharmaceuticals

Vermont Attorney General Files Suit Against Opioid Manufacturers Over Alleged Misrepresentation of Prescription Opioid Risks (Read More)



The State AG Report Weekly Update August 23, 2018


Pharmaceuticals

Massachusetts Attorney General Reaches Settlement with Pharmacy Over Alleged Violation of State Medicaid Automatic Refill Regulation (Read More)



The State AG Report Weekly Update August 16, 2018


Pharmaceuticals

New York Attorney General Files Lawsuit Against Opioid Manufacturer Over Alleged Misrepresentation of Prescription Opioid Risks (Read More)